{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:52:18Z","timestamp":1747183938301},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["heartfailure.theclinics.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.hfc.2015.08.003","type":"journal-article","created":{"date-parts":[[2015,11,11]],"date-time":"2015-11-11T21:01:23Z","timestamp":1447275683000},"page":"11-29","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Stable Ischemic Heart Disease"],"prefix":"10.1016","volume":"12","author":[{"given":"Richard","family":"Kones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umme","family":"Rumana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2015.08.003_bib1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/01.psy.0000146330.80895.77","article-title":"Chest pain in patients with cardiac and noncardiac disease","volume":"66","author":"Sheps","year":"2004","journal-title":"Psychosom Med"},{"key":"10.1016\/j.hfc.2015.08.003_bib2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ncpgasthep0284","article-title":"Diagnosis and treatment of noncardiac chest pain","volume":"2","author":"Eslick","year":"2005","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.hfc.2015.08.003_bib3","first-page":"2012","article-title":"Diagnosing the cause of chest pain","volume":"72","author":"Cayley","year":"2005","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1016\/j.hfc.2015.08.003_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.CIR.40.1.113","article-title":"Sequential alterations in myocardial lactate metabolism, S-T segments, and left ventricular function during angina induced by atrial pacing","volume":"40","author":"Parker","year":"1969","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2015.08.003_bib5","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jacc.2008.12.053","volume":"53","author":"Scirica","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2015.08.003_bib6","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/archinte.1989.00390070068008","article-title":"The Incidence and prognosis of unrecognized myocardial infarction in the Honolulu, Hawaii, Heart Program","volume":"149","author":"Yano","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hfc.2015.08.003_bib7","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.CIR.81.3.748","article-title":"Silent ischemia during daily life is an independent predictor of mortality in stable angina","volume":"81","author":"Deedwania","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2015.08.003_bib8","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0735-1097(99)00080-7","article-title":"Admission risk assessment by cardiac Troponin T in unstable coronary artery disease: additional prognostic information from continuous ST segment monitoring","volume":"33","author":"Norgaard","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2015.08.003_bib9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/CIRCULATIONAHA.106.678300","article-title":"Statin therapy and the elderly: SAGE Advice?","volume":"115","author":"Gotto","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2015.08.003_bib10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.amjmed.2013.02.026","article-title":"Encouraging trends in acute myocardial infarction survival in the oldest old","volume":"126","author":"Tjia","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.hfc.2015.08.003_bib11","first-page":"371","article-title":"The Canadian Cardiovascular Society grading of angina pectoris revisited 30 years later","volume":"18","author":"Campeau","year":"2002","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hfc.2015.08.003_bib12","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.CIR.64.6.1227","article-title":"Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale","volume":"64","author":"Goldman","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2015.08.003_bib13","series-title":"Mayo clinic practice of cardiology","first-page":"1160","article-title":"Myocardial ischemia clinical syndromes; B: angina pectoris and coronary heart disease","author":"Shub","year":"1996"},{"key":"10.1016\/j.hfc.2015.08.003_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00003246-197311000-00006","article-title":"Metabolism of the acutely ischemic and hypoxic heart","volume":"1","author":"Kones","year":"1973","journal-title":"Crit Care Med"},{"key":"10.1016\/j.hfc.2015.08.003_bib15","first-page":"1662","article-title":"Pathogenesis of cardiogenic shock II","volume":"73","author":"Kones","year":"1973","journal-title":"N\u00a0Y State J Med"},{"key":"10.1016\/j.hfc.2015.08.003_bib16","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/eurheartj\/ehl001","article-title":"Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology","volume":"27","author":"Fox","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2015.08.003_bib17","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1161\/CIR.0b013e318277d6a0","article-title":"2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/SCA\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease","volume":"126","author":"Fihn","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2015.08.003_bib18","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM197906143002402","article-title":"Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease","volume":"300","author":"Diamond","year":"1979","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2015.08.003_bib19","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.1989.03420140079032","article-title":"The evolution of medical and surgical therapy for coronary artery disease","volume":"261","author":"Califf","year":"1989","journal-title":"JAMA"},{"issue":"Suppl 4","key":"10.1016\/j.hfc.2015.08.003_bib20","first-page":"S787","article-title":"AHA Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care, Part 8: stabilization of the patient with acute coronary syndromes","volume":"112","author":"O'Connor","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2015.08.003_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/157340312801215764","article-title":"Beta blocker use after acute myocardial infarction in the patient with normal systolic function: when is it \u201cOk\u201d to discontinue?","volume":"8","author":"Kezerashvilli","year":"2012","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.hfc.2015.08.003_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.coph.2012.12.008","article-title":"Nitrate therapy and nitrate tolerance in patients with coronary artery disease","volume":"13","author":"M\u00fcnzel","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.hfc.2015.08.003_bib23","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/0002-9149(94)90283-6","article-title":"Antithrombotic properties of transdermal nitroglycerin in stable angina pectoris","volume":"73","author":"Lacoste","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2015.08.003_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/HYPERTENSIONAHA.107.103226","article-title":"Oxidative stress, nitric oxide synthase, and superoxide dismutase: a matter of imbalance underlies endothelial dysfunction in the human coronary circulation","volume":"51","author":"Schiffrin","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.hfc.2015.08.003_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.coph.2013.01.006","article-title":"Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease","volume":"13","author":"Huige","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.hfc.2015.08.003_bib26","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/01.CIR.90.2.762","article-title":"Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)","volume":"90","author":"Pepine","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2015.08.003_bib27","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A\u00a0calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2015.08.003_bib28","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1586\/14779072.6.8.1055","article-title":"The ACTION Study: nifedipine in patients with symptomatic stable angina and hypertension","volume":"6","author":"Sierra","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.hfc.2015.08.003_bib29","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1517\/14656566.2.12.1995","article-title":"Potassium channel openers: therapeutic potential in cardiology and medicine","volume":"2","author":"Jahangir","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.hfc.2015.08.003_bib30","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(02)08265-X","article-title":"Effect of nicorandil on coronary events in patients with stable angina: the Impact of Nicorandil in Angina (IONA) randomised trial","volume":"359","author":"IONA Study Group","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2015.08.003_bib31","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1067\/mhj.2000.103846","article-title":"A\u00a0comparison of nicorandil with isosorbide mononitrate in elderly patients with stable coronary heart disease: the SNAPE Study","volume":"139","author":"Ciampricotti","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2015.08.003_bib32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1253\/circj.CJ-09-0649","article-title":"Effects of nicorandil on cardiovascular events in patients with coronary artery disease in the Japanese Coronary Artery Disease (JCAD) Study","volume":"74","author":"Horinaka","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.hfc.2015.08.003_bib33","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.4244\/EIJV9I9A178","article-title":"Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study","volume":"9","author":"Hirohata","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.hfc.2015.08.003_bib34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10557-013-6456-y","article-title":"Beneficial effects of intracoronary nicorandil on microvascular dysfunction after primary percutaneous coronary intervention: demonstration of its superiority to nitroglycerin in a cross-over study","volume":"27","author":"Ito","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.hfc.2015.08.003_bib35","first-page":"87","article-title":"Critical evaluation of ivabradine for the management of chronic stable angina","volume":"2","author":"Khan","year":"2011","journal-title":"Res Reports Clin Cardiol"},{"key":"10.1016\/j.hfc.2015.08.003_bib36","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2012.06.031","article-title":"Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia. A prospective, randomized, placebo-controlled, double-blind, crossover evaluation","volume":"60","author":"Cappato","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2015.08.003_bib37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/ncpcardio1013","article-title":"Does timetazidine prevent myocardial injury after percutaneous coronary intervention?","volume":"5","author":"Marzilli","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.hfc.2015.08.003_bib38","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.RES.37.5.527","article-title":"The metabolic significance of the malate\u2013aspartate shuttle cycle in the heart","volume":"37","author":"Safer","year":"1975","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.hfc.2015.08.003_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003614.pub2","article-title":"Trimetazidine for stable angina","author":"Ciapponi","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hfc.2015.08.003_bib40","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/hrt.2009.190256","article-title":"Modification of myocardial\u00a0substrate utilisation: a new therapeutic paradigm in cardiovascular disease","volume":"96","author":"Beadle","year":"2010","journal-title":"Heart"},{"issue":"Suppl 1","key":"10.1016\/j.hfc.2015.08.003_bib41","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.33549\/physiolres.932639","article-title":"The interaction of calcium entry and calcium sensitization in the control of vascular tone and blood pressure of normotensive and hypertensive rats","volume":"63","author":"Zicha","year":"2014","journal-title":"Physiol Res"},{"key":"10.1016\/j.hfc.2015.08.003_bib42","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/CIRCRESAHA.108.188524","article-title":"ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells","volume":"104","author":"Wang","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2015.08.003_bib43","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2217\/fca.11.51","article-title":"Rho kinase as a therapeutic target in cardiovascular disease","volume":"7","author":"Surma","year":"2011","journal-title":"Future Cardiol"},{"key":"10.1016\/j.hfc.2015.08.003_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1475-2840-11-28","article-title":"High-dose fasudil preserves postconditioning against myocardial infarction under hyperglycemia in rats: role of mitochondrial KATP channels","volume":"11","author":"Ichinomiya","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.hfc.2015.08.003_bib45","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.drudis.2010.06.011","article-title":"Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases","volume":"15","author":"Dong","year":"2010","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.hfc.2015.08.003_bib46","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCEP.108.817320","article-title":"Cardiac metabolism and arrhythmias","volume":"2","author":"Barth","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hfc.2015.08.003_bib47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1520-765X(04)80002-6","article-title":"Inhibition of late (sustained\/persistent) sodium current: a potential drug target to reduce intracellular sodium dependent calcium overload and its detrimental effects on cardiomyocyte function","volume":"6","author":"Belardinelli","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2015.08.003_bib48","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.hrthm.2011.03.045","article-title":"Electrophysiological basis for the antiarrhythmic actions of ranolazine","volume":"8","author":"Antzelevitch","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hfc.2015.08.003_bib49","first-page":"1","article-title":"Ranolazine in the management of chronic stable angina","volume":"18","author":"Khan","year":"2011","journal-title":"Br J Cardol"},{"key":"10.1016\/j.hfc.2015.08.003_bib50","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jacc.2009.09.068","article-title":"B-Type Natriuretic peptide and the effect of ranolazine in patients with non-st-segment elevation acute coronary syndromes. Observations from the MERLIN-TIMI 36\u00a0Trial","volume":"55","author":"Morrow","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2015.08.003_bib51","first-page":"535","article-title":"Extended-release ranolazine: critical evaluation of its use in stable angina","volume":"7","author":"Truffa","year":"2011","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.hfc.2015.08.003_bib52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/1753944710391350","article-title":"Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention","volume":"5","author":"Kones","year":"2011","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.hfc.2015.08.003_bib53","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2147\/VHRM.S37119","article-title":"Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes","volume":"9","author":"Kones","year":"2013","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.hfc.2015.08.003_bib54","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2015.08.003_bib55","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: the American Heart Association\u2019s Strategic Impact Goal Through 2020 and Beyond","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2015.08.003_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2013.11.003","article-title":"2013 AHA\/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk: a Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","author":"Eckel","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2015.08.003_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2013.11.004","article-title":"2013 AHA\/ACC\/TOS Guideline for the Management of Overweight and Obesity in Adults: a Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","author":"Jensen","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2015.08.003_bib58","article-title":"2013 ACC\/AHA Guideline on the Assessment of Cardiovascular Risk: a Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","author":"Goff","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2015.08.003_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","author":"Stone","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2015.08.003_bib60","article-title":"AHA\/ACC\/CDC Science Advisory: an effective approach to high blood pressure control a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention","author":"Go","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.hfc.2015.08.003_bib61","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc14-S014","article-title":"Standards of medical care in diabetes\u20142014","volume":"37","author":"American Diabetes Association","year":"2014","journal-title":"Diabetes Care"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713615000719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713615000719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T08:01:27Z","timestamp":1599811287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713615000719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1551713615000719"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2015.08.003","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stable Ischemic Heart Disease","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2015.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}